

February 15, 2023 - NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials
January 4, 2023 - NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
December 6, 2022 - NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 2:00pm ET
November 15, 2022 - NanoViricides, Inc. Has Filed its Quarterly Report- Coronavirus Drug NV-CoV-2 IND Stage
October 14, 2022 - NanoViricides, Inc. Has Filed its Annual Report- Coronavirus Drug NV-CoV-2 IND Stage
NanoViricides Product Pipeline
-
VZV "Shingles" Dermal Topical Cream
-
HSV "Genital Lesions" Topical Cream
-
HSV "Cold Sores" Dermal Topical Lotion
-
HSV "Herpes Keratitis" Eye Drops
-
H1N1 "Swine Flu" Seasonal Influenzas
-
H1N1 "Swine Flu" Seasonal Influenzas
-
HIVCide™ Potentially "Functional Cure"
-
Flaviviruses Including Dengue
-
MERS Coronovirus
-
Rabies
-
Ebola, Marburg, Hemorrhagic Viruses
-
Hepatitis C

A New Era in Targeted Anti-Viral Therapeutics
Imagine coursing through the blood stream, chasing through the body, grabbing and destroying the offending virus particles. NanoViricides, Inc. is striving to bring this imagination to fruition. A nanoviricide®, as defined by the Company, is a nanomachine that is armed to destroy a particular kind of virus. Which virus? That information is programmed into the nanoviricide, akin to the postal address on an envelope.
Biomimetic Technology to "Fool" Viruses
A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune system assistance. This is the putative or designed mechanism of action of a nanoviricide. Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines), which are currently well established antiviral strategies.
NanoViricides In the News
- 01-23-2020Dr. Anil Diwan on Fox Business - 01/23/2020
- By - Kennedy
- 08-21-2018Uptick Newswire's "Stock Day" Podcast
- By - Uptick Newswire
- 08-24-2016Shelton company sets sites on fighting disease
- By - CT Post NewsTimes
- 06-26-2018Nanoviricides Prevent Varicella Zoster Virus Infection in Human Skin
- 06-24-2017Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture
Presentations and Abstracts

Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies

Ms. Vyas was First Indian woman to be named CEO of a publicly listed US corporation

Dr. Barton has over 25 years experience in drug discovery and development
Quick Links
Contact Information

NanoViricides, Inc.
1 Controls Drive,
Shelton, CT 06484
Phone: +1-203-937-6137
Phone: +1-888-591-3579
Fax: +1-203-859-5095
E-mail: info@nanoviricides.com